AI-generated summary
This is a protocol for a planned randomized pilot study comparing low-level light therapy applied to local versus distal acupoints in 60 women with moderate-to-severe primary dysmenorrhea. The authors describe pain measured by visual analog scale and multimodal biosignals as outcomes, with the study designed to explore differences rather than establish efficacy. No results are reported in the abstract.
- Participants
- 60
- Who or what was studied
- Women with moderate-to-severe primary dysmenorrhea
- Limits stated in the abstract
- The abstract states this is a pilot study not designed to establish definitive efficacy, and it reports only a protocol with no results.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background
Primary dysmenorrhea (PD) is a common gynecological condition affecting a substantial proportion of women of reproductive age. Non-steroidal anti-inflammatory drugs often provide incomplete pain relief and may be associated with adverse effects (AEs), highlighting the need for low-risk, non-pharmacological alternatives. Low-level light therapy (LLLT) has emerged as a promising non-invasive modality for pain management; however, the comparative effects of LLLT applied to local versus distal acupoints remain unclear.
Method
This is a single-center, prospective, randomized, assessor- and statistician-blinded, parallel-group pilot study. A total of 60 women with moderate-to-severe PD will be randomized to receive LLLT at either local or distal acupoints. Interventions will be administered once daily for 7 consecutive days prior to menstruation across three menstrual cycles. Pain intensity will be assessed using the visual analog scale (VAS). Multimodal biosignals, such as electrocardiography, electromyography, electrodermal activity, photoplethysmography, respiration, and skin temperature, will be recorded to explore physiological responses to treatment. The primary outcome is the change from baseline in VAS measured at the scheduled post-menstrual visit occurring within 3 days after the onset of menstruation, assessed across three menstrual cycles. The secondary outcomes include biosignal changes, patient-reported outcomes, and the Patient Global Impression of Change.
Conclusion
To the best of our knowledge, this will be one of the first randomized studies to directly compare LLLT applied to local and distal acupoints in patients with PD. As a comparative pilot study, it is not designed to establish definitive efficacy but to explore differences between stimulation strategies and to generate preliminary data for future confirmatory studies. STUDY PROTOCOL
Registration
https://cris.nih.go.kr/cris/search/detailSearch.do?seq=30497&sea. This study has been registered with the Clinical Research Information Service, identifier KCT0010827 (registration date: 29 July 2025).
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Pilot study, Low-level laser therapy, Visual analogue scale, Primary outcome. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.